Diskussionsleitung: B. Heidecker (Berlin), H. Milting (Bad Oeynhausen)
| (P510) | Endomyocardial gene expression of CXCL12 predicts mortality in patients with non-ischemic cardiomyopathy | |
| I. I. Müller, J. Hirneise, K.-P. Kreißelmeier, O. Borst, D. Heinzmann, J. Schreieck, T. Geisler, M. Gawaz, K. A. L. Müller (Tübingen) | ||
| (P511) | Newly identified variant in filamin C affecting structure and function of patient-specific pluripotent stem cell-derived cardiomyocytes of patients with dilated cardiomyopathy | |
| W. Maurer, A. Zibat, M. Tiburcy, E. Stauffenberg, G. Hasenfuß, W.-H. Zimmermann, S. T. Sossalla, B. Wollnik, K. Streckfuß-Bömeke, für die Studiengruppe: DZHK (Göttingen, Regensburg, Würzburg) | ||
| (P512) | Mechanistic differences in mouse models of Heart Failure with Preserved Ejection Fraction (HFpEF) | |
| S. Swarnkar, M. Schnelle, M. El Kenani, B. A. Mohamed, K. Toischer, D. Katschinski, G. Hasenfuß (Göttingen) | ||
| (P513) | Investigating the role of circCHPC in pathological cardiac hypertrophy | |
| W. Pan, K. Xiao, I. Riedel, S. Chatterjee, C. Bär, T. Thum (Hannover) | ||
| (P514) | Molecular diagnosis of inherited cardiac disorders using next generation sequencing: First results from the Biobank of Cardiomyopathies Ulm (BCMU) | |
| M. Baumhardt, Y. Teumer, C. Schweizer, K. Weinmann, F. Diofano, D. Scharnbeck, C. Bothner, T. Dahme, S. Just, W. Rottbauer, A. Pott, für die Studiengruppe: BCMU (Ulm) | ||
| (P515) | Nanopore Based Amplicon Sequencing is a Suitable Tool for Genetic Testing of Patients with Hypertrophic Cardiomyopathy | |
| V. Ruppert, M. Soufi, J. R. Schäfer, B. Schieffer (Marburg) | ||
| (P516) | Transcriptomics of Immune checkpoint inhibitor-associated myocarditis patients reveal inflammasome pathway activation | |
| D. Finke, M. Heckmann, J. Salatzki, L. Heinzerling, B. Meder, M. Völkers, O. J. Müller, N. Frey, H. A. Katus, F. Leuschner, Z. Kaya, L. H. Lehmann (Heidelberg, Erlangen, Kiel) |